Sanofi (SNY) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Drug Manufacturers - General
Sanofi (SNY) Profile & Business Summary
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Key Information
| Ticker | SNY |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://www.sanofi.com |
Market Trend Overview for SNY
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-08-17 (ET)
As of 2026-08-17, SNY is in a strong upward move. Over the longer term, the trend remains bullish.
SNY last closed at 44.41. The price is about 0.7 ATR above its recent average price (43.72), and the market is currently in a strong upward move. Price at 44.41 is holding above minor support near 43.36. If price continues higher, it may face minor resistance around 44.72. View Support & Resistance from Options
Short-term and long-term trends are aligned, and momentum remains healthy, supporting further upside.
Trend score: 95 out of 100. Overall alignment is strong. The market is currently in a strong and established uptrend. Trend signals are well aligned across timeframes, suggesting a stable and consistent trend.
A key downside risk boundary is near 41.41. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-07-09, reflecting a technical shift toward positive directional alignment.
[2026-08-17] Price moved quickly and looked strong, but participation was limited.Bearish signal near resistance (0.38 ATR away). Reversal risk is higher. Pattern is less clear, so strength is reduced.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Closing activity showed limited conviction and did not suggest strong overnight positioning.
The model sees a bullish edge, with 63.4% upside probability and a still-actionable balance between confirmation and reversal risk.
Up probability is 63.4%, with predictability at 55% and signal agreement at 93%. Reversal risk is 27%, while reward/risk stands at 0.21. That suggests the directional case is supported by broad confirmation and still retains usable quality. At the same time, price is still close to a gamma transition zone.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 18 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-08-17. The current price is 44.41, 2.39% above the estimated average cost of 43.37. An estimated 88.8% of recent positioning is below the current price, while 11.1% is above it. The peak-density price is 43.57. The largest concentrated cost region is 43.28 to 43.80 and contains 34.2% of the estimated distribution. The nearest region below the current price is 44.24 to 44.38. The nearest region above the current price is 45.27 to 45.34.
Short Interest & Covering Risk for SNY
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is well above normal levels, increasing the risk of forced covering and sudden price moves. (Historical percentile: 80%)
Structure Analysis
SNY Short positioning looks normal. Current days to cover is 2.7 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves. No meaningful structural fragility is currently detected (Fragility Score 19/100, DTC percentile 67%) with short positioning continuing to expand.
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
In the latest reporting period, short interest continues to increase. Price action is compressing (range is tightening), which can make breaks more sensitive. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-07-31 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.